Jonathan J. Bauer-Erickson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jonathan J. Bauer-Erickson has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Andrew P. Norwood
Interdisciplinary Biomedical Sciences, University of Arkansas for Medical Sciences, Little Rock, AR, USA
1 shared publicationBrenda M. Gannon
Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA
1 shared publicationJeffrey T. Alliston
Department of Urology, University of Arkansas for Medical Sciences, Little Rock, AR, USA
1 shared publication- Mahmoud I. Khalil
Department of Urology, University of Arkansas for Medical Sciences, Little Rock, AR, USA
1 shared publication - Michael D. Berquist
Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, 4301 W. Markham Street, Mail Slot 611, Little Rock, AR 72205, United States of America
1 shared publication - Mohamed H. Kamel
Department of Urology, University of Arkansas for Medical Sciences, Little Rock, AR, USA
1 shared publication
Latest Publications
- 27 July 2019
- Published by Springer Nature in International Urology and Nephrology
- Vol. 51 (11) , 1903-1911
Organ-sparing procedures in GU cancer: part 3-organ-sparing procedures in urothelial cancer of upper tract, bladder and urethra
The impact of radical surgery for urothelial carcinoma is significant on patient's quality of life. Organ-sparing surgery (OSS) can provide comparable oncological outcomes and with improved quality of life. In this review, we summarize the indications, techniques and outcomes of OSS for these tumors. PubMed® was searched for relevant articles. Keywords used were: for upper tract urothelial carcinoma (UTUC): endoscopic, ureteroscopic/percutaneous management, laser ablation; for urothelial bladder cancer: bladder preservation, trimodal therapy, muscle invasive bladder cancer (MIBC); for urethral cancer: urethra/penile-sparing, urethral carcinoma. Kidney-sparing surgery is an option in patients with low-risk UTUC with better renal function preservation and comparable oncological control to radical nephroureterectomy. In select patients with MIBC, trimodal therapy has better quality of life and comparable oncological control to radical cystectomy. In distal male urethral cancer, penile conserving surgery is feasible and offers acceptable survival outcomes. In female urethral cancer, organ preservation can be achieved, in addition to OSS, through radiation. In the appropriately selected patient, OSS in upper tract, bladder and urethral carcinoma has comparable oncological outcomes to radical surgery and with the additional benefit of improved quality of life.
- 27 July 2019
- Published by Springer Nature in International Urology and Nephrology
- Vol. 51 (11) , 1903-1911
Organ-sparing procedures in GU cancer: part 3-organ-sparing procedures in urothelial cancer of upper tract, bladder and urethra
The impact of radical surgery for urothelial carcinoma is significant on patient's quality of life. Organ-sparing surgery (OSS) can provide comparable oncological outcomes and with improved quality of life. In this review, we summarize the indications, techniques and outcomes of OSS for these tumors. PubMed® was searched for relevant articles. Keywords used were: for upper tract urothelial carcinoma (UTUC): endoscopic, ureteroscopic/percutaneous management, laser ablation; for urothelial bladder cancer: bladder preservation, trimodal therapy, muscle invasive bladder cancer (MIBC); for urethral cancer: urethra/penile-sparing, urethral carcinoma. Kidney-sparing surgery is an option in patients with low-risk UTUC with better renal function preservation and comparable oncological control to radical nephroureterectomy. In select patients with MIBC, trimodal therapy has better quality of life and comparable oncological control to radical cystectomy. In distal male urethral cancer, penile conserving surgery is feasible and offers acceptable survival outcomes. In female urethral cancer, organ preservation can be achieved, in addition to OSS, through radiation. In the appropriately selected patient, OSS in upper tract, bladder and urethral carcinoma has comparable oncological outcomes to radical surgery and with the additional benefit of improved quality of life.
- 1 May 2018
- Published by Elsevier in Neuropharmacology
- Vol. 134, 158-166
Phencyclidine-like in vivo effects of methoxetamine in mice and rats
- 1 May 2018
- Published by Elsevier in Neuropharmacology
- Vol. 134, 158-166
Phencyclidine-like in vivo effects of methoxetamine in mice and rats